Defiance AI & Power Infrastructure ETF vs Tenet Healthcare Corporation — how do they compare? Defiance AI & Power Infrastructure ETF trades at $28.79 (market cap $914.80M), while Tenet Healthcare Corporation trades at $261.99 (market cap $21.10B). The key difference: Tenet Healthcare Corporation is far larger — about 23.1× Defiance AI & Power Infrastructure ETF's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Defiance AI & Power Infrastructure ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Defiance AI & Power Infrastructure ETF for 2 Days and Tenet Healthcare Corporation for 14 Days on average.
| AIPO | THC | |
|---|---|---|
Market Cap | $914.80M | $21.10B |
Volume | 836,318 | 3,183,957 |
Sector | Sector/Thematic | Health |
52-Week High | $34.77 | $280.77 |
52-Week Low | $21.26 | $161.37 |
Typical Hold Time | 2 Days | 14 Days |
Enterprise Value | — | $32.17B |
Signals from Pluang's Aura AI — not financial advice
AIPO, trading at $28.51, is an ETF providing exposure to AI and power infrastructure. The stock gained 1.1% in the last session but faces a bearish technical outlook with moving averages signaling caution. Recent news highlights its role in the AI-driven infrastructure buildout, though valuation metrics like P/E are not available in the provided data.
The outlook is mixed, with growth potential from AI infrastructure demand offset by technical weakness and market volatility. Key risks include macroeconomic headwinds and sector concentration, while analyst sentiment varies between buy and hold ratings, reflecting uncertainty in near-term performance.
Tenet Healthcare (THC) trades at $261.99, showing minimal daily movement with a 0.03% gain. The stock demonstrates strong fundamental performance with consistent earnings beats (Q4 2025-Q2 2026) and attractive valuation metrics including a P/E of 10.13 and EV/EBITDA of 5.77. Technical indicators show a neutral stance overall, with bullish moving averages but neutral oscillators. Recent news highlights institutional interest and the company's refinancing activities through senior note offerings.
THC presents a compelling investment case with strong analyst support (81% buy ratings) and a $284.77 consensus price target offering 8.7% upside. The company's robust profitability (53.31% ROE) and projected revenue growth to $22.6B in 2026 support optimism. Key risks include debt refinancing execution and potential regulatory pressures in the healthcare sector. The combination of value metrics and growth prospects positions THC favorably for long-term investors.
Trailing returns across standard periods
Defiance AI & Power Infrastructure ETF seeks exposure to companies involved in AI infrastructure and the power systems that support it. Its holdings may include companies related to data centers, electricity generation, grid infrastructure, and energy storage.
Read more on AIPO →Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →